SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009330
Filing Date
2018-04-26
Accepted
2018-04-26 16:31:36
Documents
14
Period of Report
2018-06-06
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A srpt-def14a_20180606.htm DEF 14A 3388012
2 GRAPHIC g2018042521103874921569.jpg GRAPHIC 2067
3 GRAPHIC g2018042521102490621562.jpg GRAPHIC 2184
4 GRAPHIC g2018042521102499121563.jpg GRAPHIC 3818
5 GRAPHIC g2018042521103250521566.jpg GRAPHIC 5380
6 GRAPHIC g2018042521102459521561.jpg GRAPHIC 3818
7 GRAPHIC g2018042521103098621565.jpg GRAPHIC 6815
8 GRAPHIC g2018042521103941821571.jpg GRAPHIC 51459
9 GRAPHIC g2018042521103937221570.jpg GRAPHIC 71786
10 GRAPHIC g2018042521103252121568.jpg GRAPHIC 6552
11 GRAPHIC g2018042521103098421564.jpg GRAPHIC 6074
12 GRAPHIC g2018042521103250921567.jpg GRAPHIC 5272
13 GRAPHIC g2018042521102427721559.jpg GRAPHIC 3818
14 GRAPHIC g2018042521102459321560.jpg GRAPHIC 2078
  Complete submission text file 0001564590-18-009330.txt   3627154
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 18779022
SIC: 2834 Pharmaceutical Preparations